Norwest Venture Partners is a venture capital and growth equity investment firm founded in 1961 and based in Palo Alto, California. The firm specializes in early to late-stage investments across a diverse range of sectors, including technology, healthcare, consumer products, and business services. Norwest has invested in over 600 companies and currently partners with more than 140 active firms within its portfolio. The firm focuses on providing capital to companies in the United States, India, and Israel, investing amounts typically ranging from $1 million to $30 million for early-stage companies and $15 million to $100 million for growth equity investments. With a strong emphasis on helping CEOs and founders scale their businesses, Norwest leverages its extensive network and operational expertise to support the companies in which it invests.
Principal, Head of Mergers Acquisitions and Capital Markets
Yoni Braun
Vice President
Sonya Brown
General Partner and Co-Head of Growth Equity
Shiv Chaudhary
Managing Director
Priti Youssef Choksi
Partner
Casper De Clercq
General Partner
Nathan Cohen
Vice President
Jeffrey Crowe
Co-Founder and Senior Managing Partner
Ran Ding
Partner
Matthew De Dominicis
Partner and CFO
Philip Fleischman
Vice President
David Glaser
Investor
Anubha Goyal
Investor, Norwest India
Ken Graham
Investor
Aidan Greenstein
Investor
Guillermo Grimaldo
Investor
Garrett Hardesty
Investor
Ryan Harris
General Partner
Sean Jacobsohn
Partner
Trey Jennings
Senior Associate
Krish Kapadia
Vice President
Sameer Kapur
Vice President, Growth Equity
Paul Kigawa
Investor
Nikhil Kookada
Vice President
Jon Kossow
Co-Founder and Managing Partner
Parul Laddha
Investor, Norwest India
Jordan Leites
Vice President
Sam Lesser
Investor
Sonia Li
Associate
Brian Matesic
Principal
Cassie McHenry
Investor
JP McKeever
Investor
John McNeil
Investor
Ryan McDonald
Principal - Healthcare
Venkat Mohan
Operating Partner and Board Member
Brian Moon
Senior Associate
Dror Nahumi
General Partner
Michelle Nie
Investor
Ginny Pan
Investor
Connor Pike
Principal, Growth Equity
Ankit Prasad
Vice President
Irem Rami
Principal, Growth Equity and Venture
Ashwin Ravi
Associate
Gabrielle Rush
Investor
Samuel Saldarriaga
Investor
Umang Sanghvi
Investor, Norwest India
Christopher Scullin
Vice President
Rama Sekhar
Partner
Suraj Shah
Vice President
Niren Shah
Managing Director and Head of India, Norwest Venture Partners (NVP) India
Chris Sondej
Principal, Growth Equity
Gabe Stauber
Associate
Laurie Tennant
Principal, People Advisory
Matthew Uthupan
Investor
Sanchana Vasikaran
Investor
Vidushi Verma
Investor, Norwest India
Jessica Yi
Vice President
Edward Yip
Partner
Michael Zarian
Investor
Justin Zhang
Investor
David Zilberman
General Partner
Dave Zilberman
General Partner
Past deals in Health Diagnostics
Zelis
Private Equity Round in 2024
Zelis is a healthcare and financial technology company that specializes in claims cost management and payments optimization solutions. Founded in 2016 and based in Bedminster, New Jersey, Zelis provides integrated services such as network analytics, payment integrity, electronic payments, and claims communications. These offerings aim to streamline the pricing, payment, and explanation of healthcare claims for payers, healthcare providers, and consumers across medical, dental, and workers' compensation markets. By leveraging advanced technology, Zelis assists its clients in navigating the complexities of the healthcare financial landscape while ensuring compliance with evolving regulations. The company is supported by investment firms Parthenon Capital Partners and Bain Capital.
Route 92
Series F in 2024
Route 92 Medical is a medical device company founded in 2015 and based in San Mateo, California. The company specializes in developing innovative solutions for stroke treatment, focusing on a stealthy catheter designed for acute ischemic stroke. Their technology includes a percutaneous catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery mechanism. These advancements aim to assist healthcare professionals in effectively treating stroke patients and enhancing their recovery outcomes.
Courier Health
Series A in 2024
Courier Health is a developer of a patient engagement platform that focuses on delivering personalized experiences throughout the healthcare process. Its platform facilitates seamless and compliant coordination among healthcare providers, incorporating predictive intelligence and real-time analytics. This enables healthcare organizations to enhance operational efficiency and foster collaboration, ultimately aiming for improved patient outcomes.
Route 92
Series F in 2023
Route 92 Medical is a medical device company founded in 2015 and based in San Mateo, California. The company specializes in developing innovative solutions for stroke treatment, focusing on a stealthy catheter designed for acute ischemic stroke. Their technology includes a percutaneous catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery mechanism. These advancements aim to assist healthcare professionals in effectively treating stroke patients and enhancing their recovery outcomes.
Regency Healthcare
Venture Round in 2023
Regency Healthcare which started as Regency Hospital was the first, Multi-Specialty Tertiary Care Corporate Hospital in Uttar Pradesh. The Hospital was established in 1995 with a view to fill the wide gap between the demand of high quality medical services and actually available services on ground. In a span of 20 years, the hospital has been able to establish a distinct identity for delivering super specialty medical services to Kanpur, surrounding cities & rural areas.
Regency Healthcare
Secondary Market in 2023
Regency Healthcare which started as Regency Hospital was the first, Multi-Specialty Tertiary Care Corporate Hospital in Uttar Pradesh. The Hospital was established in 1995 with a view to fill the wide gap between the demand of high quality medical services and actually available services on ground. In a span of 20 years, the hospital has been able to establish a distinct identity for delivering super specialty medical services to Kanpur, surrounding cities & rural areas.
Neura Health
Seed Round in 2023
Neura Health is a venture-backed startup focused on enhancing access to and the quality of care for individuals with neurological conditions. The company has developed a virtual neurology clinic platform that allows patients to track their symptoms and share them with licensed doctors, facilitating personalized care from the comfort of their homes. This approach aims to address the significant challenges faced in neurology, including long wait times for specialist appointments and limitations in diagnosis that often rely on self-reported data. By streamlining the process of obtaining care, Neura Health seeks to improve treatment options for conditions such as migraine and chronic headaches, while also working towards a broader goal of advancing neurological research and finding potential cures.
BillionToOne
Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Nanopath
Series A in 2022
Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By utilizing advancements in bioengineering and nanotechnology, the company specializes in the sensitive detection of viral, bacterial, and fungal pathogens without relying on nucleic acid amplification techniques. This innovative approach allows for the delivery of granular and clinically actionable information, thereby improving traditional testing methodologies and enabling healthcare providers to make informed decisions more swiftly.
BillionToOne
Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Neura Health
Seed Round in 2022
Neura Health is a venture-backed startup focused on enhancing access to and the quality of care for individuals with neurological conditions. The company has developed a virtual neurology clinic platform that allows patients to track their symptoms and share them with licensed doctors, facilitating personalized care from the comfort of their homes. This approach aims to address the significant challenges faced in neurology, including long wait times for specialist appointments and limitations in diagnosis that often rely on self-reported data. By streamlining the process of obtaining care, Neura Health seeks to improve treatment options for conditions such as migraine and chronic headaches, while also working towards a broader goal of advancing neurological research and finding potential cures.
The Breakaway
Seed Round in 2022
The Breakaway is a developer of a motivational coaching app specifically designed for fitness enthusiasts, with a primary focus on cyclists. The application offers users intelligent goal-setting and personalized insights to facilitate faster progress in their fitness journeys. Additionally, it provides motivational feedback and tips from professional athletes, ensuring that users remain engaged and informed as they work towards achieving their goals.
Route 92
Series E in 2021
Route 92 Medical is a medical device company founded in 2015 and based in San Mateo, California. The company specializes in developing innovative solutions for stroke treatment, focusing on a stealthy catheter designed for acute ischemic stroke. Their technology includes a percutaneous catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery mechanism. These advancements aim to assist healthcare professionals in effectively treating stroke patients and enhancing their recovery outcomes.
Elligo Health Research
Series E in 2021
Elligo Health Research, Inc. is a healthcare organization focused on enhancing clinical research through innovative infrastructure and technology. Founded in 2016 and headquartered in Austin, Texas, the company facilitates the integration of clinical research into healthcare clinics, enabling faster development of pharmaceutical, biotechnology, and medical device products. By utilizing advanced health informatics and electronic health records, Elligo helps identify suitable patients for clinical trials and offers physicians the necessary support to conduct trials efficiently without the need for significant infrastructure investments. This approach not only accelerates patient enrollment and trial completion for sponsors but also allows patients to participate in clinical research within their own healthcare settings, minimizing logistical challenges and contributing to advancements in medical care. Additionally, Elligo empowers physicians with knowledge of emerging therapies, ultimately enhancing patient care and engagement in the research process.
BillionToOne
Series B in 2021
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Tempo
Series C in 2021
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.
TigerConnect
Series D in 2020
TigerConnect is a provider of clinical communication solutions tailored for the healthcare sector, enabling effective collaboration among doctors, nurses, patients, and care providers. Founded in 2010 and headquartered in Santa Monica, California, the company offers a platform that integrates real-time mobile messaging with a user-friendly interface, while prioritizing security and privacy. Trusted by over 4,000 healthcare organizations, TigerConnect processes more than 10 million messages daily and boasts a 99.99% uptime. Its innovative products and seamless integrations with essential hospital systems enhance workflow efficiency, ultimately accelerating productivity, reducing costs, and improving patient outcomes. The company's commitment to client success is evident through its dedicated support organization, which collaborates with clients to optimize communication workflows and maximize return on investment.
Tempo
Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.
Kyo Care
Venture Round in 2019
Gateway Learning Group is a platform for organizing and managing healthcare information. Their platform offers electronic medical records, telemedicine capabilities, appointment scheduling, and medication tracking. Gateway Learning Group also offers solutions for medical billing and revenue cycle management.
Omada
Series D in 2019
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Omada
Series C in 2017
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
NationWide Primary Healthcare Services
Series B in 2017
Founded in 2010, NationWide is the brain child of Dr. Santanu Chattopadhyay (MD, MRCP, MBA - INSEAD), and Dr. Shantanu Rahman (MRCGP, CCGTP-UK). We believe in "Bringing back the Family Doctor" in India's healthcare scenario. NationWide is proud to have a 40-member team, including several Board Certified Family Medicine Specialists and GPs from the UK and USA, who have relocated back to India with a passion to serve their own country.The company is funded by Norwest Venture Partners, a top-tier investment firm in the US and has plans to open 250 clinics across India over the next 5 years, with an aim to revolutionize the way primary care is delivered in our country.
Carecloud
Series C in 2016
CareCloud Corporation is a healthcare information technology company based in Miami, Florida, founded in 2009. It specializes in cloud-based solutions, offering a comprehensive suite of services that includes practice management, electronic health records, revenue cycle management, and patient engagement tools. CareCloud caters to various medical specialties such as dermatology, family practice, ophthalmology, podiatry, rheumatology, and urology. By leveraging its innovative software-as-a-service platforms, the company aims to enhance profitability, streamline workflows, and improve patient care for medical groups across the United States. CareCloud's data-driven tools provide actionable insights, facilitating effective management of the financial and administrative aspects of healthcare delivery. The company currently manages over $4 billion in annualized accounts receivable on its integrated clinical and financial platform. As of early 2020, CareCloud operates as a subsidiary of MTBC, Inc.
TigerConnect
Series C in 2015
TigerConnect is a provider of clinical communication solutions tailored for the healthcare sector, enabling effective collaboration among doctors, nurses, patients, and care providers. Founded in 2010 and headquartered in Santa Monica, California, the company offers a platform that integrates real-time mobile messaging with a user-friendly interface, while prioritizing security and privacy. Trusted by over 4,000 healthcare organizations, TigerConnect processes more than 10 million messages daily and boasts a 99.99% uptime. Its innovative products and seamless integrations with essential hospital systems enhance workflow efficiency, ultimately accelerating productivity, reducing costs, and improving patient outcomes. The company's commitment to client success is evident through its dedicated support organization, which collaborates with clients to optimize communication workflows and maximize return on investment.
Omada
Series C in 2015
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Crossover
Venture Round in 2015
Crossover Health, Inc. provides comprehensive workplace healthcare services tailored for employers and their employees. Founded in 2010, the company is headquartered in Aliso Viejo, California, with health centers located in various regions, including Silicon Valley. Crossover Health offers a wide range of services, including primary care, urgent care, chronic disease management, preventive care, health risk assessments, and health education. Additionally, it provides ancillary services such as physical therapy, chiropractic care, acupuncture, and care coordination, along with health analytics and remote care options. The company's focus is on creating a positive employee care experience that promotes a healthy and motivated workforce while delivering financial benefits to organizations.
Misfit Wearables
Series C in 2014
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.
iRhythm Technologies
Series E in 2014
iRhythm Technologies is a digital healthcare company that specializes in ambulatory electrocardiogram (ECG) monitoring for patients at risk of arrhythmias in the United States. Its flagship product, the Zio service, features a wire-free, patch-based biosensor designed for comfortable wear, enabling continuous monitoring of heart activity for up to 14 days. This wearable technology is complemented by a cloud-based data analytics platform that utilizes machine learning to transform extensive heartbeat data into actionable clinical insights. iRhythm aims to enhance the early diagnosis and treatment of cardiac arrhythmias, ultimately improving patient health outcomes while reducing unnecessary healthcare costs. Established in 2006 and headquartered in San Francisco, the company also collaborates with Verily Life Sciences to develop advanced atrial fibrillation monitoring solutions.
Misfit Wearables
Series B in 2013
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.
BASIS Science
Series B in 2013
At Basis our mission is to help fit health into our busy lives. We designed our wrist-based health tracker and online personal dashboard to help you easily incorporate healthy habits into your daily routine. Basis leverages four types of advanced sensors in its lightweight, customizable design to calculate steps taken, calories burned and sleep quality, as well as physiological metrics like heart rate. We help you set new health goals and automatically adjust weekly targets based on your progress. Using this flexible approach you’ll build healthy habits you can maintain for years. Basis Science, Inc. is backed by Norwest Venture Partners and Doll Capital Management.
Carecloud
Series B in 2013
CareCloud Corporation is a healthcare information technology company based in Miami, Florida, founded in 2009. It specializes in cloud-based solutions, offering a comprehensive suite of services that includes practice management, electronic health records, revenue cycle management, and patient engagement tools. CareCloud caters to various medical specialties such as dermatology, family practice, ophthalmology, podiatry, rheumatology, and urology. By leveraging its innovative software-as-a-service platforms, the company aims to enhance profitability, streamline workflows, and improve patient care for medical groups across the United States. CareCloud's data-driven tools provide actionable insights, facilitating effective management of the financial and administrative aspects of healthcare delivery. The company currently manages over $4 billion in annualized accounts receivable on its integrated clinical and financial platform. As of early 2020, CareCloud operates as a subsidiary of MTBC, Inc.
iRhythm Technologies
Series D in 2013
iRhythm Technologies is a digital healthcare company that specializes in ambulatory electrocardiogram (ECG) monitoring for patients at risk of arrhythmias in the United States. Its flagship product, the Zio service, features a wire-free, patch-based biosensor designed for comfortable wear, enabling continuous monitoring of heart activity for up to 14 days. This wearable technology is complemented by a cloud-based data analytics platform that utilizes machine learning to transform extensive heartbeat data into actionable clinical insights. iRhythm aims to enhance the early diagnosis and treatment of cardiac arrhythmias, ultimately improving patient health outcomes while reducing unnecessary healthcare costs. Established in 2006 and headquartered in San Francisco, the company also collaborates with Verily Life Sciences to develop advanced atrial fibrillation monitoring solutions.
BASIS Science
Series B in 2013
At Basis our mission is to help fit health into our busy lives. We designed our wrist-based health tracker and online personal dashboard to help you easily incorporate healthy habits into your daily routine. Basis leverages four types of advanced sensors in its lightweight, customizable design to calculate steps taken, calories burned and sleep quality, as well as physiological metrics like heart rate. We help you set new health goals and automatically adjust weekly targets based on your progress. Using this flexible approach you’ll build healthy habits you can maintain for years. Basis Science, Inc. is backed by Norwest Venture Partners and Doll Capital Management.
Nueclear Healthcare
Venture Round in 2013
Nueclear Healthcare Limited, established in 2010 as a subsidiary of Thyrocare Technologies Limited, specializes in diagnostic imaging with a focus on nuclear medicine solutions for cancer patients. As a leader in PET/CT imaging in India, the company aims to transform the healthcare landscape by developing a nationwide network of PET/CT facilities through an innovative model. Nueclear Healthcare provides essential services such as early detection, staging, and monitoring of cancer, utilizing advanced PET-CT scanners to enable timely and effective treatment for patients. The organization is dedicated to making cancer diagnostics more accessible and affordable across the country.
Thyrocare Technologies
Post in 2012
Thyrocare Technologies Limited is a leading diagnostic testing service provider in India, specializing in a wide range of medical diagnostic tests aimed at the early detection and management of various health disorders, including thyroid and metabolic diseases, diabetes, anemia, infertility, and infectious diseases. Founded in 1996 and headquartered in Navi Mumbai, the company operates through three main segments: Diagnostic Testing Services, Imaging Services, and Others. Its Diagnostic Testing Services segment, which generates the majority of revenue, offers comprehensive test profiles under the Aarogyam brand, focusing on wellness and preventive healthcare. Thyrocare is recognized as India's first fully automated diagnostic laboratory, utilizing advanced technology to deliver quality reports at affordable prices. Additionally, the company markets glucometers and glucostrips under the Sugarscan brand and operates a network of imaging centers for effective cancer monitoring.
Simpirica Spine
Series C in 2011
Simprica Spine is a stabilization system designed to stabilize the spine in flexion and helps patients rehabilitate better.
BASIS Science
Series A in 2011
At Basis our mission is to help fit health into our busy lives. We designed our wrist-based health tracker and online personal dashboard to help you easily incorporate healthy habits into your daily routine. Basis leverages four types of advanced sensors in its lightweight, customizable design to calculate steps taken, calories burned and sleep quality, as well as physiological metrics like heart rate. We help you set new health goals and automatically adjust weekly targets based on your progress. Using this flexible approach you’ll build healthy habits you can maintain for years. Basis Science, Inc. is backed by Norwest Venture Partners and Doll Capital Management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.